Redness and Dry Eye Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Redness and Dry Eye Relief
Generic name
GLYCERIN, NAPHAZOLINE HYDROCHLORIDE
Manufacturer
KC Pharmaceuticals, Inc
Product type
HUMAN OTC DRUG
SPL set ID
4682f68d-6bdd-d860-e063-6394a90a2b52
SPL ID
4682f69e-39ad-6a20-e063-6294a90a05a2
Version
1
Effective date
2025-12-21
Source export date
2026-10-12
Source partition
12
Source file
https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/edd23646015c9adc800cdbe2b778398a2d2b70e90dce5721ef2b191499a0397f/drug-label-0012-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 02:55:13
Harmonized routes table
Harmonized routes
OPHTHALMIC

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use if solution changes color or becomes cloudy Ask a doctor before use if you have narrow angle glaucoma When using this product ■ to avoid contamination, do not touch tip of container to any surface ■ replace cap after using ■ overuse may produce increased redness of the eye ■ pupils may become enlarged temporarily Stop use and ask a doctor if ■ you experience eye pain ■ you experience changes in vision ■ you experience continued redness or irritation of the eye ■ the condition worsens or persists for more than 72 hours

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.